APOE and Anxiety: After the NOL test confirmed the behavioral rescue of memory deficits, we also conducted the open field test to assess the effects of tamoxifen on locomotor activity and anxiety at experimental weeks 48 and 41 for ApoE3-KI:caMEK5 and ApoE4-KI:caMEK5, respectively.